Status:
COMPLETED
MELD ESAS Evolution: Assessment of the Symptomatic Burden of Patients With Advanced Chronic Liver Disease
Lead Sponsor:
Unidade Local de Saúde de Matosinhos, EPE
Conditions:
Palliative Care
End Stage Liver DIsease
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this observational study is to understand if there is a correlation between the evolution of MELD-Na and symptomatic burden of patients with advanced chronic liver disease. All patients w...
Detailed Description
1. Methodology - Prospective observational study 2. Population - All patients with chronic liver disease followed in the Matosinhos Local Health Unit after their first episode of decompensation or are...
Eligibility Criteria
Inclusion
- All patients with chronic liver disease
Exclusion
- do not sign consent to participate
- patients under 18 years of age
- patients who present a recurrent degree of encephalopathy, according to the West-Haven scale, equal or greater than 2
Key Trial Info
Start Date :
January 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 25 2025
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT06181474
Start Date
January 1 2024
End Date
January 25 2025
Last Update
May 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hugo Miguel Oliveira
Matosinhos Municipality, Portugal